USE OF BETASERCA IN PATIENTS WITH HD WITH COCHLEOVESTIBULAR DISORDERS

Betahistine dihydrochloride is a synthetic drug that has the ability to bind to H1 histamine receptors, which are embedded in the neuroreceptor cells of the inner ear. It has a powerful stimulating effect by increasing the release of neurotransmitters (histamine) from the nerve endings of the inner ear receptor cells into the synapse. The neurotransmitter acts on the precapillary sphincters, causing vasodilation of the vessels of the inner ear, increasing their permeability and thereby normalizing intralabyrinthine pressure, i.e. eliminating hydrops.

Ҳали таржима қилинмаган